112
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma

, , , &
Pages 5745-5756 | Published online: 28 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wang Yinzhong, Wang Miaomiao, Tian Xiaoxue, Wang Qian, Qi Meng & Lei Junqiang. (2023) Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysis. Expert Review of Molecular Diagnostics 23:1, pages 63-69.
Read now

Articles from other publishers (18)

Isabella Angeli-PahimAnastasia ChambersSergio DuarteDaiki SomaThiago BeduschiIlyas SahinSteven HughesAli Zarrinpar. (2023) Methylated ctDNA Quantification: Noninvasive Approach to Monitoring Hepatocellular Carcinoma Burden. Journal of the American College of Surgeons 238:4, pages 770-778.
Crossref
Ioana Manea, Razvan Iacob, Speranta Iacob, Razvan Cerban, Simona Dima, Gabriel Oniscu, Irinel Popescu & Liliana Gheorghe. (2023) Liquid biopsy for early detection of hepatocellular carcinoma. Frontiers in Medicine 10.
Crossref
Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, Eric Miller & Ashish Manne. (2023) Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?. International Journal of Molecular Sciences 24:18, pages 14231.
Crossref
Yichun Xu, Yong Yang, Yichao Wang, Jun Su, Tianlong Chan, Jiajing Zhou, Yi Gong, Ke Wang, Yifeng Gu, Congmeng Zhang, Guanjin Wu, Ling Bi, Xiong Qin & Junsong Han. (2023) Molecular fingerprints of nuclear genome and mitochondrial genome for early diagnosis of lung adenocarcinoma. Journal of Translational Medicine 21:1.
Crossref
Florian Roßner, Bruno Valentin Sinn & David Horst. (2023) Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. Cancers 15:2, pages 494.
Crossref
Sophie Schlosser, Deniz Tümen, Barbara Volz, Katja Neumeyer, Niklas Egler, Claudia Kunst, Hauke Christian Tews, Stephan Schmid, Arne Kandulski, Martina Müller & Karsten Gülow. (2022) HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice. Frontiers in Oncology 12.
Crossref
Ishfaq Hassan Mir, K. C. Jyothi & Chinnasamy Thirunavukkarasu. (2021) The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipation. Journal of Cellular Biochemistry 123:10, pages 1607-1623.
Crossref
Xueying Lyu, Yu-Man Tsui, Daniel Wai-Hung Ho & Irene Oi-Lin Ng. (2022) Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology 13:6, pages 1611-1624.
Crossref
Andrew D. James & William J. Brackenbury. 2022. Voltage-Gated Calcium Channels. Voltage-Gated Calcium Channels 635 657 .
Panagiota Maravelia, Daniela Nascimento Silva, Giulia Rovesti, Michael Chrobok, Per Stål, Yong-Chen Lu & Anna Pasetto. (2021) Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy. Cancers 13:17, pages 4334.
Crossref
Hunter R. Underhill. (2021) Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?. Molecular Diagnosis & Therapy 25:4, pages 389-408.
Crossref
Filippo Pelizzaro, Romilda Cardin, Barbara Penzo, Elisa Pinto, Alessandro Vitale, Umberto Cillo, Francesco Paolo Russo & Fabio Farinati. (2021) Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?. Cancers 13:9, pages 2274.
Crossref
Ting Song, Li Li, Shaobo Wu, Yan Liu, Caiping Guo, Wen Wang, Lili Dai, Tong Zhang, Hao Wu & Bin Su. (2021) Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Vincent L. Chen, Dabo Xu, Max S. Wicha, Anna S. Lok & Neehar D. Parikh. (2020) Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review. Clinical Gastroenterology and Hepatology 18:13, pages 2879-2902.e9.
Crossref
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford & Chamindie Punyadeera. (2020) The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:2, pages 188451.
Crossref
Ting Wang & Kun-He Zhang. (2020) New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Frontiers in Oncology 10.
Crossref
Sameer A. Dhayat & Zixuan Yang. (2020) Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas. Journal of Cancer Research and Clinical Oncology 146:7, pages 1625-1645.
Crossref
Tudor Mocan, André L. Simão, Rui E. Castro, Cecília M. P. Rodrigues, Artur Słomka, Bingduo Wang, Christian Strassburg, Aliona Wöhler, Arnulf G. Willms & Miroslaw Kornek. (2020) Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?. Journal of Clinical Medicine 9:5, pages 1541.
Crossref